Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Resistance Profile to Antiretroviral Medications in Individuals Living With HIV Who Failed a First-Line Regimen With Tenofovir / Lamivudina and Dolutegravir in Brasil

NCT07618507 is registered in ClinicalTrials.gov with Federal University of São Paulo as lead sponsor.

NCT NCT07618507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07618507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Resistance Profile to Antiretroviral Medications in Individuals Living With HIV Who Failed a First-Line Regimen With Tenofovir / Lamivudina and Dolutegravir in Brasil
Lead sponsor
Federal University of São Paulo
Phase
Not applicable
Overall status
Completed
Start date
April 13, 2022
Completion date
March 8, 2024
Enrollment
777 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, hiv -1 infection